Stansberry Research|
Daniel Smoot|
U.S. Late-Day Stock Moves: MYOK, EIDX, LTHM, AMC, DKNG
Advances:
MyoKardia (MYOK) +57.7%. Bristol-Myers Squibb (BMY) said it would acquire MYOK.Eidos Therapeutics (EIDX) +42.3%. The company agreed to be acquired by BridgeBio Pharma (BBIO).Livent (LTHM) +17.3%. Lithium miners have received several strong forecasts on the growing demand for Tesla (TSLA) and other car-makers' vehicles.